Evidence map›Paper›PMID 27906199›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Microduplication of the ARID1A gene causes intellectual disability with recognizable syndromic features.

Marie Bidart, Michèle El Atifi, Sarra Miladi, John Rendu, Véronique Satre, Pierre F Ray, Caroline Bosson, Françoise Devillard, Daphné Lehalle, Valérie Malan and 11 more

Open access · bronzeAbstract readCase ReportsComparative Study
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Marie BidartUF Clinatec, Pôle Recherche, INSERM UMR 1205, CHU de Grenoble, Grenoble, France.ORCID 0000-0003-4092-1253
Michèle El AtifiUF Clinatec, Pôle Recherche, INSERM UMR 1205, CHU de Grenoble, Grenoble, France.ORCID 0000-0003-1814-2720
Sarra MiladiUF Clinatec, Pôle Recherche, INSERM UMR 1205, CHU de Grenoble, Grenoble, France.ORCID 0000-0002-9139-3449
John RenduUniversité Grenoble-Alpes, Grenoble, France.
Véronique SatreUniversité Grenoble-Alpes, Grenoble, France.
Pierre F RayUniversité Grenoble-Alpes, Grenoble, France.
Caroline BossonDépartement de Biochimie Toxicologie et Pharmacologie, Département de Biochimie Génétique et Moléculaire, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
Françoise DevillardDépartement de Génétique et Procréation, Hôpital Couple-Enfant, CHU de Grenoble, Grenoble, France.
Daphné LehalleService de Génétique, INSERM U781, Hôpital Necker-Enfants Malades, Institut Imagine, University Sorbonne-Paris-Cité, Paris, France.ORCID 0000-0002-2193-8685
Valérie MalanService de Cytogénétique et UMR_S1163, IHU Imagine, Hôpital Necker-Enfants Malades, Paris, France.ORCID 0000-0002-3450-4958
Jeanne AmielService de Génétique, INSERM U781, Hôpital Necker-Enfants Malades, Institut Imagine, University Sorbonne-Paris-Cité, Paris, France.
Maria Antonietta MencarelliGenetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Margherita BaldassarriGenetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.ORCID 0000-0002-0391-1980
Alessandra RenieriGenetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Jill Clayton-SmithManchester Centre for Genomic Medicine, Central Manchester University Hospitals, Manchester Academic Health Sciences Centre, Manchester, UK.
Gaëlle VievilleDépartement de Génétique et Procréation, Hôpital Couple-Enfant, CHU de Grenoble, Grenoble, France.
Julien ThevenonCentre de Génétique et Centre de Référence "Anomalies du Développement et Syndromes Malformatifs," Hôpital d'Enfants, CHU Dijon, Dijon, France.
Florence AmblardDépartement de Génétique et Procréation, Hôpital Couple-Enfant, CHU de Grenoble, Grenoble, France.
François BergerUF Clinatec, Pôle Recherche, INSERM UMR 1205, CHU de Grenoble, Grenoble, France.ORCID 0000-0001-7221-0718
Pierre-Simon JoukUniversité Grenoble-Alpes, Grenoble, France.ORCID 0000-0001-8301-320X
Charles CouttonUniversité Grenoble-Alpes, Grenoble, France.
Centre Hospitalier Universitaire de Grenoble · FRHôpital Couple Enfant · FRUniversité Grenoble Alpes · FRInserm · FRUniversity of Siena · ITAzienda Ospedaliera Universitaria Senese · ITHôpital d'Enfants · FRHôpital Necker-Enfants Malades · FRSorbonne Paris Cité · FRUniversité Paris Cité · FRUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine whether duplication of the ARID1A gene is responsible for a new recognizable syndrome.

methodsWe describe four patients with a 1p36.11 microduplication involving ARID1A as identified by array-comparative genomic hybridization . We performed comparative transcriptomic analysis of patient-derived fibroblasts using RNA sequencing and evaluated the impact of ARID1A duplication on the cell cycle using fluorescence-activated cell sorting. Functional relationships between differentially expressed genes were investigated with ingenuity pathway analysis (IPA).

resultsCombining the genomic data, we defined a small (122 kb), minimally critical region that overlaps the full ARID1A gene. The four patients shared a strikingly similar phenotype that included intellectual disability and microcephaly. Transcriptomic analysis revealed the deregulated expression of several genes previously linked to microcephaly and developmental disorders as well as the involvement of signaling pathways relevant to microcephaly, among which the polo-like kinase (PLK) pathway was especially notable. Cell-cycle analysis of patient-derived fibroblasts showed a significant increase in the proportion of cells in G1 phase at the expense of G2-M cells.

conclusionOur study reports a new microduplication syndrome involving the ARID1A gene. This work is the first step in clarifying the pathophysiological mechanism that links changes in the gene dosage of ARID1A with intellectual disability and microcephaly.Genet Med advance online publication 01 December 2016.

Indexed as

Chromosomes, Human, Pair 1Gene DuplicationAdolescentAdultChildDNA-Binding ProteinsFemaleGene Expression ProfilingHumansIntellectual DisabilityMaleNuclear ProteinsSyndromeTranscription FactorsARID1A protein, humanDNA-Binding ProteinsNuclear ProteinsTranscription Factors

Identifiers

PMID27906199
OpenAlexW2558637609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.